Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Tau proteins"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review Article
Article image
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Junghwan Shin, Han-Joon Kim, Beomseok Jeon
J Mov Disord. 2020;13(1):11-19.   Published online December 19, 2019
DOI: https://doi.org/10.14802/jmd.19057
  • 12,246 View
  • 483 Download
  • 20 Web of Science
  • 20 Crossref
AbstractAbstract PDF
α-Synuclein and tau deposition in the central nervous system is responsible for various parkinsonian syndromes, including Parkinson’s disease, multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Emerging evidence has suggested that pathologic α-synuclein and tau are transmitted from cell to cell and further accelerate the aggregation of pathologic proteins in neighboring cells. Furthermore, extracellular pathologic proteins have also been reported to provoke inflammatory responses that lead to neurodegeneration. Therefore, immunotherapies targeting extracellular α-synuclein and tau have been proposed as potential disease-modifying strategies. In this review, we summarize completed phase I trials and ongoing phase II trials of immunotherapies against α-synuclein and tau and further discuss concerns and hurdles to overcome in the future.

Citations

Citations to this article as recorded by  
  • Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
    Wen Li, Jia-Yi Li
    Translational Neurodegeneration.2024;[Epub]     CrossRef
  • Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
    Dnyandev G. Gadhave, Vrashabh V. Sugandhi, Saurav Kumar Jha, Sopan N. Nangare, Gaurav Gupta, Sachin Kumar Singh, Kamal Dua, Hyunah Cho, Philip M. Hansbro, Keshav Raj Paudel
    Ageing Research Reviews.2024; 99: 102357.     CrossRef
  • Modeling the dynamics of innate and adaptive immune response to Parkinson's disease with immunotherapy
    Salma M. Al-Tuwairqi, Asma A. Badrah
    AIMS Mathematics.2023; 8(1): 1800.     CrossRef
  • Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy
    Winston T. Chu, Jesse Hall, Anjela Gurrala, Alexander Becsey, Shreya Raman, Michael S. Okun, Catherine T. Flores, Benoit I. Giasson, David E. Vaillancourt, Vinata Vedam-Mai
    ACS Chemical Neuroscience.2023; 14(2): 235.     CrossRef
  • Direct digital sensing of protein biomarkers in solution
    Georg Krainer, Kadi L. Saar, William E. Arter, Timothy J. Welsh, Magdalena A. Czekalska, Raphaël P. B. Jacquat, Quentin Peter, Walther C. Traberg, Arvind Pujari, Akhila K. Jayaram, Pavankumar Challa, Christopher G. Taylor, Lize-Mari van der Linden, Titus
    Nature Communications.2023;[Epub]     CrossRef
  • Inflammation in multiple system atrophy
    Marta Leńska-Mieciek, Natalia Madetko-Alster, Piotr Alster, Leszek Królicki, Urszula Fiszer, Dariusz Koziorowski
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
    Jacqui T. Nimmo, Harry Smith, Chang Yi Wang, Jessica L. Teeling, James A. R. Nicoll, Ajay Verma, Jean-Cosme Dodart, Zhi Liu, Feng Lin, Roxana O. Carare
    Acta Neuropathologica.2022; 143(1): 55.     CrossRef
  • Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
    Changyoun Kim, Armine Hovakimyan, Karen Zagorski, Tatevik Antonyan, Irina Petrushina, Hayk Davtyan, Gor Chailyan, Jonathan Hasselmann, Michiyo Iba, Anthony Adame, Edward Rockenstein, Marcell Szabo, Mathew Blurton-Jones, David H. Cribbs, Anahit Ghochikyan,
    npj Vaccines.2022;[Epub]     CrossRef
  • Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
    Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim
    Journal of Movement Disorders.2022; 15(1): 1.     CrossRef
  • Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
    Dhanya Vijayakumar, Joseph Jankovic
    CNS Drugs.2022; 36(4): 327.     CrossRef
  • Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
    Urmi Sengupta, Rakez Kayed
    Progress in Neurobiology.2022; 214: 102270.     CrossRef
  • Modeling the dynamics of innate immune response to Parkinson disease with therapeutic approach
    Asma Badrah, Salma Al-Tuwairqi
    Physical Biology.2022; 19(5): 056004.     CrossRef
  • Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease
    Le Zhao, Dan Li, Xiaofen Qi, Kaifang Guan, Haoran Chen, Rongchun Wang, Ying Ma
    Food & Function.2022; 13(21): 10851.     CrossRef
  • Harnessing the immune system for the treatment of Parkinson’s disease
    Vinata Vedam-Mai
    Brain Research.2021; 1758: 147308.     CrossRef
  • The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
    Katja Badanjak, Sonja Fixemer, Semra Smajić, Alexander Skupin, Anne Grünewald
    International Journal of Molecular Sciences.2021; 22(9): 4676.     CrossRef
  • Viral alpha-synuclein knockdown prevents spreading synucleinopathy
    Sindhu Menon, Rikke H Kofoed, Fadl Nabbouh, Kristiana Xhima, Yasmeen Al-Fahoum, Tammy Langman, Howard T J Mount, Lamya S Shihabuddin, S Pablo Sardi, Paul E Fraser, Joel C Watts, Isabelle Aubert, Anurag Tandon
    Brain Communications.2021;[Epub]     CrossRef
  • Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
    Somin Kwon, Michiyo Iba, Changyoun Kim, Eliezer Masliah
    Neurotherapeutics.2020; 17(3): 935.     CrossRef
  • The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
    Kyu-Young Sim, Kyeong Chan Im, Sung-Gyoo Park
    International Journal of Molecular Sciences.2020; 21(15): 5295.     CrossRef
  • Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
    Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
    Alzheimer's Research & Therapy.2020;[Epub]     CrossRef
  • New Insights Into Drug Discovery Targeting Tau Protein
    Yoshiyuki Soeda, Akihiko Takashima
    Frontiers in Molecular Neuroscience.2020;[Epub]     CrossRef

JMD : Journal of Movement Disorders Twitter
Close layer
TOP